These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21309120)

  • 1. Cannabinoids and anxiety.
    Moreira FA; Wotjak CT
    Curr Top Behav Neurosci; 2010; 2():429-50. PubMed ID: 21309120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D; Centonze D; Petrosini L
    Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
    Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
    Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
    J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?
    Moreira FA; Aguiar DC; Terzian AL; Guimarães FS; Wotjak CT
    Neuroscience; 2012 Mar; 204():186-92. PubMed ID: 21906661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids, cannabinoids and the regulation of anxiety.
    Petrie GN; Nastase AS; Aukema RJ; Hill MN
    Neuropharmacology; 2021 Sep; 195():108626. PubMed ID: 34116110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system in Huntington's disease.
    Pazos MR; Sagredo O; Fernández-Ruiz J
    Curr Pharm Des; 2008; 14(23):2317-25. PubMed ID: 18781982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity.
    Kim SR; Chung YC; Chung ES; Park KW; Won SY; Bok E; Park ES; Jin BK
    Mol Neurobiol; 2007 Jun; 35(3):245-54. PubMed ID: 17917113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in
    Oakes M; Law WJ; Komuniecki R
    J Neurosci; 2019 May; 39(21):4142-4152. PubMed ID: 30886012
    [No Abstract]   [Full Text] [Related]  

  • 18. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional role of the endocannabinoid system in emotional homeostasis].
    Marco EM; Viveros MP
    Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.